Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.64 – $10.56
16% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3M | $890.2K | $1.6M | $2.7M | $3.0M | $498.9K | $63.8K | $0 |
| Cost of revenue | $5.0M | $691.8K | $1.8M | $4.8M | $6.0M | $5.1M | $6.7M | $956.2K |
| Gross profit | $294.3K | $198.3K | −$166.5K | −$2.1M | −$3.1M | −$4.6M | −$6.6M | −$956.2K |
| Gross margin | 5.5% | 22.3% | -10.4% | -77.9% | -102.1% | -929.0% | -10328.5% | — |
| R&D | $322.3K | $714.3K | $1.9M | $11.4M | $6.8M | $7.4M | $1.5M | $1.4M |
| Operating income | −$2.2M | −$8.5M | −$10.1M | −$33.1M | −$23.3M | −$28.2M | −$19.4M | −$10.5M |
| EBITDA | −$1.9M | −$7.8M | −$9.9M | −$32.3M | −$22.0M | −$32.9M | −$15.8M | −$49.1M |
| Net income | −$16.0M | −$8.8M | −$10.8M | −$33.1M | −$22.9M | −$34.2M | −$1.8M | −$28.2M |
| Net margin | -301.3% | -993.0% | -671.0% | -1234.7% | -766.9% | -6846.9% | -2752.5% | — |
| EPS (diluted) | -39.08 | -24.04 | -3.14 | -7.54 | -9.90 | -8.19 | -2.02 | -32.24 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds SBLX.
No tracked institution reports a position in SBLX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-06-26 | 1-for-16reverse |
No one on the platform has traded SBLX yet.
| $373953 |
| — |
| IVDAIveda Solutions, Inc. | $0.34 | +0.30% | $949749 | — |
| LICNLichen International Limited | $1.00 | -1.96% | $761829 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.